Clinical Trial Update: Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome [NA]

View source ↗

Summary

A clinical trial is studying the effect of glucagon-like peptide-2 on intestinal blood flow in patients with Short bowel syndrome. The current status of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Glucagon-like peptide-2 (glucagon-like peptide-2)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Short Bowel Syndrome | NA | Status: UNKNOWN